Department of Cranio-Maxillo-Facial and Oral Surgery, University Hospital Zurich, Zurich, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Dentomaxillofac Radiol. 2022 Feb 1;51(2):20210036. doi: 10.1259/dmfr.20210036. Epub 2021 Aug 18.
To investigate whether dynamic contrast-enhanced (DCE)-MR bone perfusion could serve as surrogate for morphologic ultra-short echo time (UTE) bone images and to correlate perfusion with morphologic hallmarks in histologically proven foci of medication-related osteonecrosis of the jaw (MRONJ).
Retrospective study including 20 patients with established diagnosis of MRONJ. Qualitative consensus assessment of predefined jaw regions by two radiologists was used as reference standard using Likert scale (0-3) for standard imaging hallmarks in MRONJ (osteolysis, sclerosis, periosteal thickening). DCE-MRI measurements performed in corresponding regions of the mandible were then correlated with qualitative scores. Regions were grouped into "non-affected" and "pathologic" based on binarized Likert scores of different imaging hallmarks (0-1 2-3). DCE-MRI measurements among hallmarks were compared using Mann-Whitney--testing. ROC (receiver-operating-characteristic) analysis was performed for each of the perfusion parameters to assess diagnostic performance for identification of MRONJ using morphologic ratings as reference standard.
Median perfusion measurements of "pathologic" regions in wash-in, peak enhancement intensity and integrated area under the curve are significantly higher than those of "non-affected" regions, irrespective of reference imaging hallmark ( < 0.05). No significant perfusion differences were found between "pathologic" regions with and without osteolysis ( = 0.180). ROC analysis showed fair diagnostic performance of DCE-MRI parameters for identification of MRONJ (AUC 0.626-0.727).
DCE bone perfusion parameters are significantly increased in MRONJ compared to non-affected regions, irrespective of osteolysis. Due to certain overlap DCE-MRI bone perfusion cannot serve as full surrogate for UTE bone imaging but may enhance reader confidence.
探究动态对比增强(DCE)-MR 骨灌注能否作为形态超短回波时间(UTE)骨图像的替代物,并将灌注与组织学证实的药物相关性下颌骨坏死(MRONJ)病灶的形态学特征相关联。
回顾性研究纳入 20 例经证实的 MRONJ 患者。两名放射科医生使用 Likert 量表(0-3)对预设的颌骨区域进行定性共识评估,用于 MRONJ 的标准影像学特征(骨质溶解、硬化、骨膜增厚)的参考标准。然后,将下颌骨相应区域的 DCE-MRI 测量值与定性评分相关联。根据不同影像学特征的二分 Likert 评分(0-1 2-3),将区域分为“无病变”和“病变”。使用 Mann-Whitney--检验比较各特征之间的 DCE-MRI 测量值。对每个灌注参数进行 ROC(受试者工作特征)分析,以评估使用形态学评分作为参考标准识别 MRONJ 的诊断性能。
“病变”区域的灌注测量值在洗脱期、峰值增强强度和曲线下面积的中位值明显高于“无病变”区域,与参考影像学特征无关( < 0.05)。“病变”区域中有无骨质溶解的灌注差异无统计学意义( = 0.180)。ROC 分析显示,DCE-MRI 参数对识别 MRONJ 的诊断性能为中等(AUC 0.626-0.727)。
与非病变区域相比,MRONJ 中的 DCE 骨灌注参数显著增加,与骨质溶解无关。由于存在一定的重叠,DCE-MRI 骨灌注不能完全替代 UTE 骨成像,但可以增强读者的信心。